Personalized pancreatic cancer vaccine that uses mRNA technology to fight tumors show promise

vaccine
Credit: Christian Emmer (CC BY-NC 4.0)

Pancreatic cancer is one of the most lethal malignancies, fatal in 88% of patients. It is also one of the hardest to treat. Tumors can be surgically removed, but they come back within seven to nine months in 90% of patients. Chemotherapy can help prolong life, but it too is rarely a cure. Radiation, immunotherapy and targeted therapies also don’t work.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Of the 16 patients who were able to complete all phases of the study, eight responded to the vaccine, which taught their immune systems how to recognize and fight off the cancer cells. None of those eight has seen their cancer return.

For this first study, doctors surgically removed the patients’ tumors and sent the tissue to a lab in Germany where scientists sequenced genetic code from the tumors and from the patients’ blood. They compared those sets of genes to find the ones that were altered in the cancer cells. After they identified the changed genes, they ran them through a computer program to let it pick the ones that would make the most effective targets.

Then they made their personalized mRNA vaccines. Patients got eight doses, which were infused into their bloodstream rather than injected into their muscles, as the Covid-19 vaccines are.

This is an excerpt. Read the full article here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.